Abstract:Objective The purpose of this study was to investigate the clinical significance of serum vascular endothelial growth factor(S-VEGF)in patients of esophageal squamous cell carcinoma with the end-point of progress-free survival rate.Methods Sera from 89 patients with esophageal squamous carcinoma,who presented and treated with concurrent chemoradiotherapy or surgical resection in Cancer Center d Sun Yat-Sen University from December 2002 to May 2004,were sampled at the time of pre-treatment.30 cases of health individuals without any evidence of disease were selected as control group.For patients with surgical resection were performed with esophagectomy and extended lymphadenectomy.For patients with concurrent chemoradiotherapy comprised of cisplatin and 5-fluorouracil.The radiotherapy dose of 2 Gy per day was initiated on Day 1 of chemotherapy and continued daily for 5 days per week for 6 weeks,for a total close of 60 Gy.Two courses of chemotherapy were given during radiotherapy at 6-week intervals.The serum vascular endothelial growth factor(S- VEGF)levels were measured with a solid phase enzyme Human VEGF Immunoassay ELISA kit.The end point of this study was progress-free survival,and time was calculated from the date of diagnosis to date of relapse or last follow evaluation.Results S-VEGF level of patients with esophageal squamous cell carcinoma was significantly higher than that of heahhy controls(475.93±44.76 pg/ml vs.294.20±23.40 pg/ml;P=0.020).S-VEGF levels in patients with StageⅢand StageⅣdisease were significantly higher than those in patients with Stage I and StageⅡdisease.The 1-year progress-free survival rate d high S-VEGF group(≥475 pg/ml)was significantly lower than that of the low S-VEGF group(＜475 pg/ml)(24% vs.66%;P=0.0004).The 1-year progress-free survival rate of the patients with StageⅠand StageⅡdisease was significantly higher than that of patients with StageⅢand StageⅣdisease(71% vs.29%;P=0.0015).The variables were assessed by multivariate analysis using the Cox proportional hazards model,and the results revealed that the clinical stage and the S-VEGF were first and second independent prognosis factor,respectively.Conclusions In the current study,a high S-VEGF was found to be associated with tumor progression,poor treatment response,and poor survival in patients with squamous cell carcinoma of the esophagus.

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF SURVIVIN AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN ESOPHAGEAL CANCER

Expression and Clinical Significance of HIF-1α, VEGF and Survivin in Esophageal Squamous Cell Carcinoma

Expressions of HIF-1α and Survivin in Esophageal Squamous Cell Carcinoma and Their Effect on Prognosis after Radiotherapy

Relationship Between Survivin Expression and Chemoradiotherapy Response in Esophageal Squamous Cell Carcinoma

Expression of vascular endothelial growth factor and Survivin in esophageal cancer and their relations with pathological manifestation

Expressions and significances of survivin and vascular endothelial growth factor in esophageal cancer

Clinical Significance of S-VEGF in Patients with Esophageal Cancer

The expressions of survivin and nm23-h1 genes in esophageal squamous cell carcinoma and the clinical significance of the combined detection

Expression and Clinical Significance of Survivin and P63 Protein in Esophageal Squamous Carcinoma

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Expression of HIF-1α and Its Prognostic Significance in Esophageal Squamous Cell Carcinoma

Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.

Expression of vascular endothelial growth factor and proliferation cell nuclear antigen in esophageal carcinoma treated by radiotherapy

Expression and Clinical Significance of HSP90α and Survivin in Esophageal Squamous Cell Carcinoma

Relationship of expressions of HIF-1α, VEGF and EGFR in esophageal squamous cell carcinoma to radiation therapy efficacy

The Relationship Between Plasma Vascular Endothelial Growth Factor and Clinicopathological Parameters in Patients with Esophageal Squamous Cell Carcinoma

[Expression of Survivin and Its Significance in Esophageal Cancer].

The Expression and Clinical Significance of HIF-1α, Survivin,CyclinD 1 in Esophageal Squamous Cancer

Expressions of Survivin,p16 and their clinical significance in esophageal carcinoma

Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases]

Expression of VEGF and Its Correlation with Prognosis of Small Cell Lung Cancer